Built on years of R&D, we develop the technologies and products the market needs.

Hello,
I am Seongwook Yang, CEO of XenoHelix.
As a professor at the University of Copenhagen, I lost several colleagues suddenly. It taught me that early diagnosis is vital, even in one of the world's top welfare states. That conviction drew me deeper into diagnostic research, and in 2019 I founded XenoHelix.

To build diagnostics entirely on our own technology, we started with the fundamentals: efficient nucleic acid extraction from diverse samples and biomarker detection.

With this proprietary core technology, we have developed molecular diagnostics for diseases such as fatty liver disease, and commercialized advanced skincare ingredients including natural exosomes and miPDRN.

Great products create real value for consumers and the market. Through that value, XenoHelix will grow into a trusted global biotech company.

Seongwook Yang, CEO of XenoHelix